MedPath

The Effect of Intrauterine Injection of Granulocyte Stimulant Factor on the Success of Intrauterine Sperm inseminatio

Phase 3
Conditions
Female infertility.
Female infertility
Registration Number
IRCT20191122045466N1
Lead Sponsor
Ardabil University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
40
Inclusion Criteria

Infertility

Exclusion Criteria

Endometriosis
Uterine Surgery History

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pregnancy. Timepoint: 3 weeks after intervention. Method of measurement: Sonography.
Secondary Outcome Measures
NameTimeMethod
Human chorionic gonadotropin hormone. Timepoint: Two weeks after intervention. Method of measurement: Laboratory.
© Copyright 2025. All Rights Reserved by MedPath